Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Coagulation inhibitors

Citations 31-40 of 44 total displayed.

Past content (since Apr 2001):

Articles
Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor
Jing Zhang, Orlando Piro, Lan Lu, and George J. Broze, Jr
Circulation published June 30, 2003, doi:10.1161/01.CIR.0000078642.45127.7B [Abstract]  

AHA/ACC Scientific Statement
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Jack Hirsh, Valentin Fuster, Jack Ansell, and Jonathan L. Halperin
Circulation 2003;107:1692-1711, doi:10.1161/01.CIR.0000063575.17904.4E [Full text]  

Editorials
Platelet Glycoprotein IIb/IIIa Inhibition and Atheroembolism During Bypass Graft Angioplasty: A Cup Half Full
Dean J. Kereiakes
Circulation 2002;106:2994-2996, doi:10.1161/01.CIR.0000041222.31560.65 [Full text]  

Cardiology Patient Pages
Treatment of Blood Clots
Samuel Z. Goldhaber and Nicole Grasso-Correnti
Circulation 2002;106:e138-140e, doi:10.1161/01.CIR.0000038923.61628.3D [Full text]  

Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation 2002;106:2550-2554; published online before print as doi:10.1161/01.CIR.0000038501.87442.02 [Abstract] [Full text]  

Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation published October 21, 2002, doi:10.1161/01.CIR.0000038501.87442.02 [Abstract]  

Editorials
Acute Pulmonary Embolism: Don’t Ignore the Platelet
Piotr Sobieszczyk, Michael C. Fishbein, and Samuel Z. Goldhaber
Circulation 2002;106:1748-1749, doi:10.1161/01.CIR.0000035277.48823.01 [Full text]  

Basic Science Reports
Antithrombin-Heparin Covalent Complex: A Possible Alternative to Heparin for Arterial Thrombosis Prevention
Anthony K.C. Chan, Janusz Rak, Leslie Berry, Peng Liao, Michal Vlasin, Jeffrey Weitz, and Petr Klement
Circulation 2002;106:261-265; published online before print as doi:10.1161/01.CIR.0000021431.88095.78 [Abstract] [Full text]  

Articles
Antithrombin-Heparin Covalent Complex. A Possible Alternative to Heparin for Arterial Thrombosis Prevention
Anthony K.C. Chan, Janusz Rak, Leslie Berry, Peng Liao, Michal Vlasin, Jeffrey Weitz, and Petr Klement
Circulation published June 17, 2002, doi:10.1161/01.CIR.0000021431.88095.78 [Abstract]  

Clinical Investigations and Reports
First Experience With Direct Factor Xa Inhibition in Patients With Stable Coronary Disease: A Pharmacokinetic and Pharmacodynamic Evaluation
Christopher K. Dyke, Richard C. Becker, Neal S. Kleiman, Judith S. Hochman, Edwin G. Bovill, A. Michael Lincoff, Gary Gerstenblith, Vladimir Dzavik, Laura H. Gardner, Vic Hasselblad, Linda A. Zillman, Yoshimasa Shimoto, Thomas L. Robertson, Satoshi Kunitada, Paul W. Armstrong, and Robert A. Harrington
Circulation 2002;105:2385-2391; published online before print as doi:10.1161/01.CIR.0000016351.12759.52 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5

* Subspecialty Collections Home

* Show  Coagulation inhibitors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors